OptimizeRx (OPRX) Return on Capital Employed (2011 - 2026)
OptimizeRx recorded quarterly Return on Capital Employed of 8.79% in Q1 2026, up 14.38% quarter-over-quarter from 7.68% in Q4 2025, and up 1592.0% year-over-year from 0.52% in Q1 2025.
OptimizeRx's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 8.79% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 1592.0% year-over-year to 8.79%; the TTM figure through Mar 2026 stood at 8.79% (up 1592.0% YoY), while the FY2025 annual figure was 7.65%, up 1629.0% from the prior year.
- Return on Capital Employed came in at 8.79% for Q1 2026 at OptimizeRx, up from 7.68% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 8.79% in Q1 2026 to a low of 19.42% in Q4 2023.
- A 5-year average of 7.66% and a median of 9.17% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed tumbled 1034 bps in 2023 and soared 2275 bps in 2025, its largest moves.
- OptimizeRx's Return on Capital Employed stood at 9.69% in 2022, then tumbled by 100 bps to 19.42% in 2023, then surged by 53 bps to 9.17% in 2024, then soared by 184 bps to 7.68% in 2025, then rose by 14 bps to 8.79% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 8.79%, 7.68%, and 4.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 13.28% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.09% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -163.65% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 21.81% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 4.73% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -4.23% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 4.60% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.23% |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn | 8.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.79% |
| Dec 31, 2025 | 7.68% |
| Sep 30, 2025 | 4.47% |
| Jun 30, 2025 | -2.60% |
| Mar 31, 2025 | -7.13% |
| Dec 31, 2024 | -9.17% |
| Sep 30, 2024 | -18.28% |
| Jun 30, 2024 | -14.55% |
| Mar 31, 2024 | -14.92% |
| Dec 31, 2023 | -19.42% |
| Sep 30, 2023 | -14.21% |
| Jun 30, 2023 | -13.66% |
| Mar 31, 2023 | -12.42% |
| Dec 31, 2022 | -9.69% |
| Sep 30, 2022 | -7.97% |
| Jun 30, 2022 | -5.14% |
| Mar 31, 2022 | -2.08% |
| Dec 31, 2021 | 0.28% |
| Sep 30, 2021 | 0.87% |
| Jun 30, 2021 | 0.72% |
| Mar 31, 2021 | -0.58% |
| Dec 31, 2020 | -4.48% |
| Sep 30, 2020 | -12.23% |
| Jun 30, 2020 | -17.33% |
| Mar 31, 2020 | -12.96% |
| Dec 31, 2019 | -7.95% |
| Sep 30, 2019 | -3.43% |
| Jun 30, 2019 | 2.23% |
| Mar 31, 2019 | 2.36% |
| Dec 31, 2018 | 0.99% |
| Sep 30, 2018 | 0.40% |
| Jun 30, 2018 | -7.08% |
| Mar 31, 2018 | -20.21% |
| Dec 31, 2017 | -34.10% |
| Sep 30, 2017 | -35.38% |
| Jun 30, 2017 | -28.06% |
| Mar 31, 2017 | -28.76% |
| Dec 31, 2016 | -20.53% |
| Sep 30, 2016 | -20.61% |
| Jun 30, 2016 | -15.75% |
| Mar 31, 2016 | -9.26% |
| Dec 31, 2015 | -6.68% |
| Sep 30, 2015 | 0.75% |
| Jun 30, 2015 | -7.26% |
| Mar 31, 2015 | -7.97% |
| Dec 31, 2014 | -23.96% |
| Sep 30, 2014 | -23.65% |
| Jun 30, 2014 | -19.99% |
| Mar 31, 2014 | -12.87% |
| Dec 31, 2013 | 39.38% |
| Sep 30, 2013 | 17.91% |
| Jun 30, 2013 | 23.41% |
| Mar 31, 2013 | -3.85% |
| Dec 31, 2012 | -31.83% |
| Sep 30, 2012 | -60.66% |
| Jun 30, 2012 | -85.91% |
| Mar 31, 2012 | -90.38% |
| Dec 31, 2011 | -99.06% |
| Sep 30, 2011 | -58.81% |